Press release
Orphan Drugs Market Research 2018: Global Industry Top Players (Novartis AG, Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd. And Pfizer, Inc.)
Research for Markets
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Orphan Drugs in these regions, from 2013 to 2025 (forecast), covering
• North America
• Europe
• China
• Japan
• Southeast Asia
• India
Looking for More Information on This Market Get Free Sample Report @ http://www.researchformarkets.com/sample/global-orphan-drugs-market-50053
Global Orphan Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• Novartis AG
• Bristol-Myers Squibb Company
• Celgene Corporation
• F. Hoffmann-La Roche Ltd.
• Pfizer, Inc.
• Sanofi S.A.
• Alexion Pharmaceuticals, Inc.
• Eli Lilly and Company
• Novo Nordisk A/S
• AstraZeneca
• Eisai Co., Ltd.
• Daiichi Sankyo Company Limited
• Bayer AG
• GlaxoSmithKline
• Merck & Co., Inc.
• Johnson & Johnson
• Biogen, Inc.
• Shire
• Amgen, Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• Oncology
• Gastrointestinal
• Pulmonary
• Neurology
• Hematology
• Cardio-vascular
• Metabolic disorders
• Endocrinology
• Infectious diseases
• Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
• Hospital Pharmacies
• Speciality Pharmacies
• Retail pharmacies
• Others
The report is available on discount for a limited time only @ http://www.researchformarkets.com/discount/global-orphan-drugs-market-50053
Table of Content
1 Orphan Drugs Market Overview
1.1 Product Overview and Scope of Orphan Drugs
1.2 Orphan Drugs Segment By Concentration levels
1.3 Orphan Drugs Segment By Technology
1.5 Global Orphan Drugs Market by Region (2013-2025)
1.6 Global Market Size (Value) of Orphan Drugs (2013-2025)
2 Global Orphan Drugs Market Competition by Manufacturers
2.1 Global Orphan Drugs Capacity, Production and Share by Manufacturers (2013-2018)
2.2 Global Orphan Drugs Revenue and Share by Manufacturers (2013-2018)
2.3 Global Orphan Drugs Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Orphan Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Orphan Drugs Market Competitive Situation and Trends
3 Global Orphan Drugs Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Orphan Drugs Capacity and Market Share by Region (2013-2018)
3.2 Global Orphan Drugs Production and Market Share by Region (2013-2018)
3.3 Global Orphan Drugs Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Orphan Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Orphan Drugs Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Orphan Drugs Consumption by Region (2013-2018)
4.2 North America Orphan Drugs Production, Consumption, Export, Import (2013-2018)
4.3 Europe Orphan Drugs Production, Consumption, Export, Import (2013-2018)
4.4 China Orphan Drugs Production, Consumption, Export, Import (2013-2018)
5 Global Orphan Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Orphan Drugs Production and Market Share by Type (2013-2018)
5.2 Global Orphan Drugs Revenue and Market Share by Type (2013-2018)
5.3 Global Orphan Drugs Price by Type (2013-2018)
5.4 Global Orphan Drugs Production Growth by Type (2013-2018)
6 Global Orphan Drugs Market Analysis by Application
6.1 Global Orphan Drugs Consumption and Market Share by Application (2013-2018)
6.2 Global Orphan Drugs Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
7 Global Orphan Drugs Manufacturers Profiles/Analysis
7.1 Novartis AG
7.2 Bristol-Myers Squibb Company
7.3 Celgene Corporation
7.4 F. Hoffmann-La Roche Ltd.
7.5 Pfizer, Inc.
7.6 Sanofi S.A.
7.7 Alexion Pharmaceuticals, Inc.
7.8 Eli Lilly and Company
7.10 Novo Nordisk A/S
8 Orphan Drugs Manufacturing Cost Analysis
8.1 Orphan Drugs Key Raw Materials Analysis
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Orphan Drugs
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Orphan Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Orphan Drugs Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.2 Market Positioning
Looking for more insights from this report @ http://www.researchformarkets.com/reports/global-orphan-drugs-market-50053
About Research for Markets:
Research for Markets indulges in detailed and diligent research on different markets, trends and emerging opportunities in the successive direction to cater to your business needs. We have established the pillars of our flourishing institute on the grounds of Credibility and Reliability. RFM delve into the markets across Asia Pacific, North America, South America, Europe, Middle East and Africa.
Our purpose is to serve you, the most customized in-depth Market access data. Our plethora of titles made us one of the most searched market research library across the globe. We work with the most esteemed Publishers around the globe who caters vast industries. We are quick and fragile, when it comes to your various queries, and we ensure our team caters your needs to the best of our abilities, we promise to stay by your side for both pre and post sales servicing, as we believe in long everlasting symbiotic relationship.
Contact:
Mr. A Naidu
Research for Markets
Tel: +44 8000-4182-37 (UK)
Email: alan.naidu@researchformarkets.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Orphan Drugs Market Research 2018: Global Industry Top Players (Novartis AG, Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd. And Pfizer, Inc.) here
News-ID: 1025018 • Views: …
More Releases from Research for Markets
Oilfield Services Market Competitive Outlook with Baker Hughes, a GE company, Ha …
The market report titled Oilfield Services Market has company analysis, history, and future overview, global sales trends by 2025. It will be one of the most comprehensive and important additions for growth of the business through Oilfield Services Market research studies. The Oilfield Services Market research report comprises of a detailed analysis of the vendor landscape and thorough company profiling of leading players of the worldwide market. This business document…
Annuloplasty Rings Market Competitive Outlook | Medtronic, Edwards Lifesciences, …
Global Annuloplasty Rings Market analysis report is a historical overview and comprehensive study on the current & future market of the ABC industry. This business research document puts forward an in-depth evaluation of each crucial aspect of the worldwide market that relates to the Annuloplasty Rings Market size, market share, market growth factor, key vendors, revenue, top regions, industry trends, product demand, sales volume, capacity, cost structure,…
Ventilators Market Top Players are are benefiting from the coronavirus | BD, GE …
The Ventilators Market report has been generated by considering a common theme throughout the marketing industry that suggests strategy and research need stronger alignment. RFM team has firm expertise in making extensive reports that cover all the necessary details about Ventilators Market assessments such as major technological improvement in the industry. The information and flow of this Ventilators Market report can be employed by marketers from all walks of…
ICU Ventilator Market Competitive Outlook | Getinge, Koninklijke Kentalis, Phili …
ICU Ventilator Market report enables clients to enhance business efficiency and focus on other core aspects of operations rather than wasting time in market research and reporting needs. ICU Ventilator Market instructions provided in this market analysis report are very specific and research-backed. For getting customization of the report, reach RFM team via email or phone. This ICU Ventilator Market analysis report delivers key data about the product portfolios, product…
More Releases for Orphan
Acquired Orphan Blood Disease Market
Acquired Orphan Blood Disease Market to reach over USD 18.93 billion by the year 2031 - Exclusive Report by InsightAce Analytic
According to a new report by InsightAce Analytic, the "Acquired Orphan Blood Disease Market" in terms of revenue was estimated to be worth $8.65 billion in 2023 and is poised to reach $18.93 billion by 2031, growing at a CAGR of 10.47% from 2024 to 2031.
Get Free Access to…
Orphan Drugs Market Size to Hit $3199.3 Billion by 2028 | Orphan Drugs Industry …
Market Overview:
According to our experience research team, Orphan Drugs Market was valued at USD 112.36 Billion in 2021, and the global Orphan Drugs industry is projected to reach a value of USD 3199.3 Billion by 2028, at a CAGR of 7.4% during the forecast period 2022-2028
Vantage Market Research is a collection of market research studies on several industries, such as Chemicals, semiconductors & Electronics, Food & Beverages Technology, Energy &…
Orphan Drugs for Cancer Pipeline Analysis
A huge market opportunity is offered by small patient population which suffers from rare or orphan diseases. Among the category of new orphan drugs, Oncology account for the largest disease group in recent years. It has been observed that majority of the orphan drugs in the clinical stages are for rare cancer disease drugs, and are in the late stages of the pipeline. Some of the drugs are being developed…
US Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the pharmaceuticals industry.…
Europe Orphan Drugs Pipeline Analysis
“Europe Orphan Drugs Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles under Orphan Drugs status in Europe. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. The information for particular drug…
Global Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US & Europe, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the…
